VBI-2902
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
(Learn how and when to remove this template message)
|
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Virus-like particles |
Clinical data | |
Routes of administration | Intramuscular |
Part of a series on the |
COVID-19 pandemic |
---|
|
By continent
By conveyance |
International response |
Socio-economic
By industry |
COVID-19 portal |
VBI-2902 is a COVID-19 vaccine candidate developed by Variation Biotechnologies.
Development[edit]
In early 2020, in collaboration with NRC the VBI's vaccine—VBI-2900—was developed. According to the company, they have two vaccine candidates—"enveloped virus-like particle (eVLP)".[1] VBI-2901 is a "trivalent pan-coronavirus vaccine expressing the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins". VBI-2902 is a "monovalent COVID-19-specific vaccine expressing the SARS-CoV-2 spike protein".[1] By March 9, the initial Phase 1/2 study of VBI-2902 was underway.[1] VBI received CA$56 million from the federal government towards the COVID-19 vaccine development.[2] The company's CEO, Jeff Baxter, said that VBI-2902 is cheaper to produce than other vaccines.
References[edit]
- ^ a b c "VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902". VBI Vaccines. 9 March 2021. Retrieved 22 March 2021.
- ^ "Podcast: Kemptville's next boom, Variation Biotechnologies' $56M injection, Vanier 'gateway'" (Podcast). Behind the Headlines. August 2020. Retrieved 22 March 2021.
External links[edit]
Scholia has a profile for VBI-2902 (Q106405764). |
Development | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|
This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |
This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |
- Articles lacking reliable references from March 2021
- All articles lacking reliable references
- Articles with a promotional tone from March 2021
- All articles with a promotional tone
- Articles with multiple maintenance issues
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from March 2021
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- All stub articles